Discover the most talked about and latest scientific content & concepts.

High serum serotonin in sudden infant death syndrome

OPEN Proceedings of the National Academy of Sciences of the United States of America | 5 Jul 2017

RL Haynes, AL Frelinger, EK Giles, RD Goldstein, H Tran, HP Kozakewich, EA Haas, AJ Gerrits, OJ Mena, FL Trachtenberg, DS Paterson, GT Berry, K Adeli, HC Kinney and AD Michelson
Sudden infant death syndrome (SIDS), the leading cause of postneonatal infant mortality, likely comprises heterogeneous disorders with the common phenotype of sudden death without explanation upon postmortem investigation. Previously, we reported that ∼40% of SIDS deaths are associated with abnormalities in serotonin (5-hydroxytryptamine, 5-HT) in regions of the brainstem critical in homeostatic regulation. Here we tested the hypothesis that SIDS is associated with an alteration in serum 5-HT levels. Serum 5-HT, adjusted for postconceptional age, was significantly elevated (95%) in SIDS infants (n = 61) compared with autopsied controls (n = 15) [SIDS, 177.2 ± 15.1 (mean ± SE) ng/mL versus controls, 91.1 ± 30.6 ng/mL] (P = 0.014), as determined by ELISA. This increase was validated using high-performance liquid chromatography. Thirty-one percent (19/61) of SIDS cases had 5-HT levels greater than 2 SDs above the mean of the controls, thus defining a subset of SIDS cases with elevated 5-HT. There was no association between genotypes of the serotonin transporter promoter region polymorphism and serum 5-HT level. This study demonstrates that SIDS is associated with peripheral abnormalities in the 5-HT pathway. High serum 5-HT may serve as a potential forensic biomarker in autopsied infants with SIDS with serotonergic defects.
Facebook likes*
News coverage*
SC clicks
High performance liquid chromatography, 5-HTTLPR, Infancy, Chromatography, Infant mortality, Death, Serotonin, Sudden infant death syndrome
MeSH headings
comments powered by Disqus

* Data courtesy of